546 related articles for article (PubMed ID: 33052069)
21. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
[TBL] [Abstract][Full Text] [Related]
22. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer.
Shi J; Li YJ; Yan B; Wei PK
Oncol Rep; 2015 Jun; 33(6):2703-10. PubMed ID: 25891418
[TBL] [Abstract][Full Text] [Related]
24. Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.
Tzeng HE; Chang AC; Tsai CH; Wang SW; Tang CH
Oncotarget; 2016 Jun; 7(25):38566-38578. PubMed ID: 27229532
[TBL] [Abstract][Full Text] [Related]
25. ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Krüppel-Like Factors 2 and 4.
Choi D; Park E; Jung E; Seong YJ; Hong M; Lee S; Burford J; Gyarmati G; Peti-Peterdi J; Srikanth S; Gwack Y; Koh CJ; Boriushkin E; Hamik A; Wong AK; Hong YK
Circ Res; 2017 Apr; 120(9):1426-1439. PubMed ID: 28167653
[TBL] [Abstract][Full Text] [Related]
26. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
27. Modulation of VEGF-induced migration and network formation by lymphatic endothelial cells: Roles of platelets and podoplanin.
Langan SA; Navarro-Núñez L; Watson SP; Nash GB
Platelets; 2018 Jul; 29(5):486-495. PubMed ID: 28727496
[TBL] [Abstract][Full Text] [Related]
28. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
[TBL] [Abstract][Full Text] [Related]
29. Walking the Line: A Fibronectin Fiber-Guided Assay to Probe Early Steps of (Lymph)angiogenesis.
Mitsi M; Schulz MM; Gousopoulos E; Ochsenbein AM; Detmar M; Vogel V
PLoS One; 2015; 10(12):e0145210. PubMed ID: 26689200
[TBL] [Abstract][Full Text] [Related]
30. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.
Durré T; Morfoisse F; Erpicum C; Ebroin M; Blacher S; García-Caballero M; Deroanne C; Louis T; Balsat C; Van de Velde M; Kaijalainen S; Kridelka F; Engelholm L; Struman I; Alitalo K; Behrendt N; Paupert J; Noel A
Nat Commun; 2018 Dec; 9(1):5178. PubMed ID: 30518756
[TBL] [Abstract][Full Text] [Related]
31. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
32. Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
Ou JJ; Wei X; Peng Y; Zha L; Zhou RB; Shi H; Zhou Q; Liang HJ
Cancer Lett; 2015 Mar; 358(2):200-209. PubMed ID: 25543087
[TBL] [Abstract][Full Text] [Related]
33. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
34. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
Coso S; Zeng Y; Opeskin K; Williams ED
PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
[TBL] [Abstract][Full Text] [Related]
36. Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow.
Helm CL; Zisch A; Swartz MA
Biotechnol Bioeng; 2007 Jan; 96(1):167-76. PubMed ID: 17133613
[TBL] [Abstract][Full Text] [Related]
37. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
38. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices.
Bayless KJ; Davis GE
Biochem Biophys Res Commun; 2003 Dec; 312(4):903-13. PubMed ID: 14651957
[TBL] [Abstract][Full Text] [Related]
40. Characterization of lymphangiogenesis in a model of adult skin regeneration.
Rutkowski JM; Boardman KC; Swartz MA
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1402-10. PubMed ID: 16648194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
